Table 1 Demographics and comorbidities
From: Decreasing use of pancreatic necrosectomy and NSQIP predictors of complications and mortality
Clavien-Dindo 4 complication | Mortality | All cases | |
|---|---|---|---|
Number (%) | 831 (33.8%) | 212 (8.6%) | 2457 (100%) |
Mean age (± SD) | 54.7 (± 14) | 54.0 (± 14) | 54.3 (± 14) |
Mean BMI (± SD) | 32.4 (± 10) | 29.1 (± 8.1) | 29.5 (± 8.6) |
Sex | |||
Male | 34.6% | 5.8% | 70.1% |
Female | 32.0% | 2.8% | 29.9% |
Non-white race | 33.1% | 35.6% | 27.8% |
Alcohol use | 14.4% | 8.4% | 8.7% |
Smoker | 23.1% | 22.7% | 22.7% |
Diabetes | 69.0% | 32.0% | 33.0% |
Hypertension on meds | 66.7% | 62.6% | 58.8% |
CHF within 30 days | 5.6% | 5.8% | 2.6% |
MI within 30 days | 0.5% | 2.4% | 0.8% |
Chronic steroid use | 3.7% | 6.1% | 4.4% |
Emergency surgery | 59.9% | 49.5% | 26.9% |
Functional status | |||
Independent | 52.2% | 52.8% | 73.8% |
Partially dependent | 8.9% | 10.5% | 10.3% |
Totally dependent | 38.8% | 36.5% | 15.1% |